These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 8820798)

  • 1. Mitoxantrone: a review of its pharmacological properties and use in acute nonlymphoblastic leukaemia.
    Dunn CJ; Goa KL
    Drugs Aging; 1996 Aug; 9(2):122-47. PubMed ID: 8820798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group.
    Arlin Z; Case DC; Moore J; Wiernik P; Feldman E; Saletan S; Desai P; Sia L; Cartwright K
    Leukemia; 1990 Mar; 4(3):177-83. PubMed ID: 2179638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitoxantrone as a single agent and in combination chemotherapy in patients with refractory acute leukemia.
    Paciucci PA; Cuttner J; Holland JF
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):36-40. PubMed ID: 6385264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitoxantrone in the treatment of acute myelogenous leukemia: a review.
    Thomas X; Archimbaud E
    Hematol Cell Ther; 1997 Aug; 39(4):63-74. PubMed ID: 9352324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acute non lymphoid leukemia (ANLL) in elderly patients. The GIMEMA experience.
    Resegotti L
    Leukemia; 1992; 6 Suppl 2():72-5. PubMed ID: 1578948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of common salvage chemotherapy regimens in patients with refractory or relapsed acute myeloid leukemia: A retrospective cohort study.
    Xu J; Lv TT; Zhou XF; Huang Y; Liu DD; Yuan GL
    Medicine (Baltimore); 2018 Sep; 97(39):e12102. PubMed ID: 30278488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitoxantrone for refractory and relapsed acute leukemia.
    Bezwoda WR; Bernasconi C; Hutchinson RM; Winfield DA; de Bock R; Mandelli F
    Cancer; 1990 Aug; 66(3):418-22. PubMed ID: 2194640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of remission in acute promyelocytic leukemia with mitoxantrone.
    Mittelman A; Rieber E; Friedland ML; Arlin ZA
    Cancer Chemother Pharmacol; 1985; 14(1):81-2. PubMed ID: 3855290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I-II trial of mitoxantrone in acute leukemia: an interim report.
    Arlin ZA; Dukart G; Schoch I; Reisman A; Moore J; Silver RA; Cassileth P; Bertino J; Gams R
    Invest New Drugs; 1985; 3(2):213-7. PubMed ID: 3860491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amsacrine, cytarabine and thioguanine (AAT) versus daunorubicin, cytarabine, thioguanine (DAT) in adults with untreated acute non-lymphoblastic leukemia (ANLL). Austrian-German results.
    Linkesch W; Michlmayr G; Gerhartz H; Illinger H; König H; Düllmann J; Keilhauer R; Moldrzyk D
    Onkologie; 1989 Feb; 12(1):8-10. PubMed ID: 2654791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daunorubicin in patients with relapsed and refractory acute nonlymphoblastic leukemia previously treated with anthracycline.
    Velu T; Debusscher L; Stryckmans P
    Am J Hematol; 1988 Mar; 27(3):224-5. PubMed ID: 3162347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapy of adult ANLL].
    Kyo T; Maehama S
    Rinsho Ketsueki; 1989 Aug; 30(8):1157-62. PubMed ID: 2601024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children's Cancer Group Study 2951.
    Wells RJ; Adams MT; Alonzo TA; Arceci RJ; Buckley J; Buxton AB; Dusenbery K; Gamis A; Masterson M; Vik T; Warkentin P; Whitlock JA;
    J Clin Oncol; 2003 Aug; 21(15):2940-7. PubMed ID: 12885813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitoxantrone in combination with etoposide and cytarabine for treatment of poor prognosis acute non lymphoid leukemia patients.
    Tribalto M; Cantonetti M; Catalano G; Del Poeta G; Masi M; Pastore S; Pisani F; Stasi R; Papa G
    Haematologica; 1991; 76(5):402-5. PubMed ID: 1806445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group.
    Löwenberg B; Suciu S; Archimbaud E; Haak H; Stryckmans P; de Cataldo R; Dekker AW; Berneman ZN; Thyss A; van der Lelie J; Sonneveld P; Visani G; Fillet G; Hayat M; Hagemeijer A; Solbu G; Zittoun R
    J Clin Oncol; 1998 Mar; 16(3):872-81. PubMed ID: 9508168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I clinical and pharmacokinetic evaluation of high-dose mitoxantrone in combination with cytarabine in patients with acute leukemia.
    Feldman EJ; Alberts DS; Arlin Z; Ahmed T; Mittelman A; Baskind P; Peng YM; Baier M; Plezia P
    J Clin Oncol; 1993 Oct; 11(10):2002-9. PubMed ID: 8410125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed engraftment of 4-hydroperoxycyclophosphamide-purged autologous bone marrow after induction treatment containing mitoxantrone for acute myelogenous leukemia.
    Damon LE; Rugo HS; Ries CA; Linker CA
    Bone Marrow Transplant; 1996 Jan; 17(1):93-9. PubMed ID: 8673063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential studies on the role of mitoxantrone in the treatment of acute leukemia.
    Prentice HG; Wimperis JZ; Robbins G
    Invest New Drugs; 1985; 3(2):207-12. PubMed ID: 3894280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of refractory or relapsed adult acute leukemia by using mitoxantrone-containing regimens.
    Lin MT; Chen YC; Liu TW; Tien HF; Liu MC; Wang CH; Shen MC; Liu CH
    Taiwan Yi Xue Hui Za Zhi; 1989; 88(11-12):1116-22. PubMed ID: 2636248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.